Divi's Laboratories Limited (DIVISLAB.BO)
INR 5389.5
(2.42%)
INR 5389.5
(2.42%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 25.43 Billion INR | -18.73% |
| 2022 | 27.13 Billion INR | -32.12% |
| 2021 | 39.97 Billion INR | 36.65% |
| 2020 | 29.23 Billion INR | 49.58% |
| 2019 | 20.12 Billion INR | -2.26% |
| 2018 | 20.26 Billion INR | 45.21% |
| 2017 | 13.76 Billion INR | -9.13% |
| 2016 | 15.2 Billion INR | -0.06% |
| 2015 | 15.12 Billion INR | 24.8% |
| 2014 | 12.1 Billion INR | 11.59% |
| 2013 | 10.2 Billion INR | 26.73% |
| 2012 | 8.59 Billion INR | 15.22% |
| 2011 | 7.45 Billion INR | 41.79% |
| 2010 | 5.26 Billion INR | 52.01% |
| 2009 | 3.46 Billion INR | -31.22% |
| 2008 | 4.99 Billion INR | -94.82% |
| 2007 | 97.08 Billion INR | 3918.75% |
| 2006 | 2.41 Billion INR | 100.48% |
| 2005 | 1.2 Billion INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 6.23 Billion INR | -23.09% |
| 2023 Q3 | 5.84 Billion INR | 3.36% |
| 2023 FY | - INR | -18.73% |
| 2023 Q2 | 5.65 Billion INR | -3.42% |
| 2023 Q1 | 5.85 Billion INR | 5.71% |
| 2023 Q4 | 7.31 Billion INR | 25.17% |
| 2022 Q3 | 5.22 Billion INR | -25.46% |
| 2022 FY | - INR | -32.12% |
| 2022 Q1 | 9.36 Billion INR | -19.2% |
| 2022 Q2 | 7.01 Billion INR | -25.11% |
| 2022 Q4 | 5.53 Billion INR | 5.91% |
| 2021 Q2 | 8.37 Billion INR | -5.73% |
| 2021 Q3 | 11.13 Billion INR | 33.04% |
| 2021 Q4 | 11.58 Billion INR | 4.01% |
| 2021 FY | - INR | 36.65% |
| 2021 Q1 | 8.88 Billion INR | 20.12% |
| 2020 FY | - INR | 49.58% |
| 2020 Q4 | 7.39 Billion INR | 4.05% |
| 2020 Q3 | 7.1 Billion INR | -5.86% |
| 2020 Q2 | 7.54 Billion INR | 5.21% |
| 2020 Q1 | 7.17 Billion INR | 54.27% |
| 2019 FY | - INR | -2.26% |
| 2019 Q3 | 5.35 Billion INR | -0.38% |
| 2019 Q2 | 5.37 Billion INR | 28.78% |
| 2019 Q4 | 4.65 Billion INR | -13.17% |
| 2019 Q1 | 4.17 Billion INR | -2.89% |
| 2018 Q1 | 4.01 Billion INR | 0.0% |
| 2018 FY | - INR | 45.21% |
| 2018 Q4 | 4.29 Billion INR | -24.22% |
| 2018 Q3 | 5.67 Billion INR | -5.75% |
| 2018 Q2 | 6.01 Billion INR | 50.1% |
| 2017 FY | - INR | -9.13% |
| 2016 FY | - INR | -0.06% |
| 2015 FY | - INR | 24.8% |
| 2014 Q4 | 3.16 Billion INR | 0.0% |
| 2014 FY | - INR | 11.59% |
| 2013 Q4 | 2.74 Billion INR | 0.0% |
| 2013 FY | - INR | 26.73% |
| 2012 Q4 | 2.53 Billion INR | 0.0% |
| 2012 FY | - INR | 15.22% |
| 2011 FY | - INR | 41.79% |
| 2010 FY | - INR | 52.01% |
| 2009 FY | - INR | -31.22% |
| 2008 FY | - INR | -94.82% |
| 2007 FY | - INR | 3918.75% |
| 2006 FY | - INR | 100.48% |
| 2005 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 9.61 Billion INR | -164.436% |
| Aurobindo Pharma Limited | 61.78 Billion INR | 58.843% |
| Glenmark Life Sciences Limited | 6.86 Billion INR | -270.544% |
| Granules India Limited | 8.6 Billion INR | -195.566% |
| Indoco Remedies Limited | 2.64 Billion INR | -860.691% |
| Achyut Healthcare Limited | 524 Thousand INR | -4852953.435% |
| Ajanta Pharma Limited | 12.56 Billion INR | -102.381% |
| Alkem Laboratories Limited | 24.19 Billion INR | -5.104% |
| Alpa Laboratories Limited | 86.12 Million INR | -29426.165% |
| Brooks Laboratories Limited | 41.72 Million INR | -60842.293% |
| AstraZeneca Pharma India Limited | 2.35 Billion INR | -979.005% |
| Bajaj HealthCare Limited | 444.51 Million INR | -5620.829% |
| Bliss GVS Pharma Limited | 1.47 Billion INR | -1619.37% |
| Dr. Reddy's Laboratories Limited | 88.27 Billion INR | 71.192% |
| Eris Lifesciences Limited | 6.98 Billion INR | -263.99% |
| FDC Limited | 4.4 Billion INR | -477.733% |
| Glenmark Pharmaceuticals Limited | 11.34 Billion INR | -124.177% |
| Gufic Biosciences Limited | 1.48 Billion INR | -1617.679% |
| Ind-Swift Laboratories Limited | 6.86 Billion INR | -270.611% |
| Ipca Laboratories Limited | 13.29 Billion INR | -91.21% |
| Jagsonpal Pharmaceuticals Limited | 323.46 Million INR | -7761.869% |
| Krebs Biochemicals & Industries Limited | -82.72 Million INR | 30839.662% |
| Lasa Supergenerics Limited | -65.08 Million INR | 39174.985% |
| Laurus Labs Limited | 8 Billion INR | -217.637% |
| Lupin Limited | 36.96 Billion INR | 31.213% |
| Mankind Pharma Limited | 28.09 Billion INR | 9.485% |
| Medicamen Biotech Limited | 245.66 Million INR | -10251.706% |
| Medico Remedies Limited | 150.37 Million INR | -16810.718% |
| Megasoft Limited | 284.73 Million INR | -8831.237% |
| NATCO Pharma Limited | 18.79 Billion INR | -35.302% |
| Piramal Pharma Limited | 13.05 Billion INR | -94.785% |
| RPG Life Sciences Limited | 1.28 Billion INR | -1884.393% |
| Sigachi Industries Limited | 883.39 Million INR | -2778.657% |
| Sun Pharmaceutical Industries Limited | 138.36 Billion INR | 81.621% |
| Suven Pharmaceuticals Limited | 4.67 Billion INR | -443.703% |
| Syncom Formulations (India) Limited | 430.27 Million INR | -5810.16% |
| Unichem Laboratories Limited | 742.35 Million INR | -3325.58% |
| Wanbury Limited | 985.49 Million INR | -2480.442% |
| Windlas Biotech Limited | 781.72 Million INR | -3153.083% |
| ZIM Laboratories Limited | 462.09 Million INR | -5403.174% |
| Zydus Lifesciences Limited | 56.22 Billion INR | 54.769% |
| Sun Pharma Advanced Research Company Limited | -3.73 Billion INR | 781.538% |
| Hester Biosciences Limited | 539.47 Million INR | -4613.886% |
| Procter & Gamble Health Limited | 3.01 Billion INR | -743.617% |
| Amrutanjan Health Care Limited | 682.53 Million INR | -3625.8% |
| Bal Pharma Limited | 345.59 Million INR | -7258.388% |
| Strides Pharma Science Limited | 3.76 Billion INR | -575.489% |
| Venus Remedies Limited | 711.8 Million INR | -3472.628% |
| Aarti Pharmalabs Limited | 3.9 Billion INR | -550.48% |
| Nectar Lifesciences Limited | 1.56 Billion INR | -1526.177% |
| Shilpa Medicare Limited | 2.58 Billion INR | -882.619% |
| Aarti Drugs Limited | 3.24 Billion INR | -682.792% |
| IOL Chemicals and Pharmaceuticals Limited | 2.6 Billion INR | -875.6% |
| Suven Life Sciences Limited | -992.78 Million INR | 2661.494% |
| Ind-Swift Limited | 1.06 Billion INR | -2287.645% |
| Valiant Laboratories Limited | 12.73 Million INR | -199523.204% |
| J. B. Chemicals & Pharmaceuticals Limited | 9.33 Billion INR | -172.421% |
| Solara Active Pharma Sciences Limited | -2.82 Billion INR | 1001.166% |
| Themis Medicare Limited | 562.6 Million INR | -4420.029% |
| Hikal Limited | 2.69 Billion INR | -844.57% |
| Torrent Pharmaceuticals Limited | 35 Billion INR | 27.363% |
| Sequent Scientific Limited | 549.8 Million INR | -4525.318% |
| Novartis India Limited | 1.26 Billion INR | -1903.466% |
| Wockhardt Limited | 1.08 Billion INR | -2254.63% |
| Jubilant Pharmova Limited | 8 Billion INR | -217.637% |
| Biofil Chemicals and Pharmaceuticals Limited | 13.06 Million INR | -194586.878% |
| Neuland Laboratories Limited | 4.74 Billion INR | -435.573% |
| Morepen Laboratories Limited | 1.72 Billion INR | -1373.388% |
| Kilitch Drugs (India) Limited | 287.42 Million INR | -8747.525% |
| Mangalam Drugs & Organics Limited | 174.94 Million INR | -14435.914% |